Plant-Based vs. Conventional Calorie-Restricted Diet Trial Results for Obesity
by Kelibinuer Mutailipu·Updated 2mo ago
23.3 KB1files
Available on 1 platform
Sign in to view source links and access this dataset
Description
A 12-week randomized, open-label, non-inferiority trial involving 80 obese adults in China, comparing plant-based caloric restriction (PB-CRD) to conventional calorie restriction (CRD). The dataset, authored by Kelibinuer Mutailipu and last updated in April 2026, contains results on weight loss, body composition, and metabolic markers. Both groups achieved significant weight loss, with PB-CRD demonstrating non-inferiority and superior reductions in body fat percentage.
Use Cases
Compare weight loss efficacy between dietary interventions based on the reported primary outcome of weight change.
Analyze changes in metabolic health markers based on secondary outcomes like glucose, lipid, and liver function.
Model the impact of dietary patterns on body composition based on reported changes in total body fat and visceral fat mass.
Assess adherence and trial completion rates based on the reported 65% completion rate across both groups.
Strengths
Data originates from a structured 12-week randomized clinical trial with 80 participants, providing a controlled experimental basis.
Results include specific numerical outcomes for weight loss (e.g., 5.11 kg vs. 6.56 kg) and body fat reduction (2.96% difference) with confidence intervals.
The dataset is shared under a permissive CC-BY-4.0 license, allowing for reuse and redistribution.
Limitations
The dataset is a 23.3 KB DOCX file, suggesting it is a supplementary document or summary, not a raw, structured data table.
Column-level documentation is absent; field semantics must be inferred from the textual description after download.
Row count is unknown, which may limit suitability assessment for quantitative analysis.
Provenance
Source
figshare, authored by Kelibinuer Mutailipu.
Collection Method
Collected via a 12-week randomized, open-label, non-inferiority clinical trial (Identifier ChiCTR1800015156).
Time Range
Trial duration was 12 weeks; specific calendar dates are not provided.
Freshness
Last updated 2026-04-13 04:35:40; freshness should be verified.
Geography
The clinical trial was registered in China (ChiCTR identifier), suggesting the study was conducted there.
The primary file format is DOCX, which may require specific software or conversion for programmatic data extraction.